News | January 05, 2009

Cancer Reverses Natural Suicide to Return Post-Treatment

December 5, 2008 - The ability for cancer cells to reverse a natural self-destruction process may attribute to the reason cancer can return after treatment, according to new research published in the British Journal of Cancer.

Apoptosis is a type of programmed cell suicide that allows the body to rid itself of damaged and potentially dangerous cells. In the recent study, led by Professor Ming-Chiu Fung, from the Chinese University of Hong Kong, researchers showed that cancer cells can reverse this process, regaining their shape and function while continuing to divide.

In the study, chemicals used on human cervical, skin, liver and breast cancer cells initiated apoptosis. Normally, there is a "point of no return" in most cells where they are driven to suicide, even when the death trigger is removed, but researchers found cancer cells crossing this point were still able to recover once the suicide-inducing chemicals had been eliminated.

They only failed to survive once the nuclei containing the bulk of their DNA began to disintegrate, an event right at the end of the cell suicide process.

According to Fung, the finding provides new clues as to what drives cancer cells to come back to life after chemotherapy treatment, and to what extent the ability for cancer cells to reverse cell death contributes to their continued division and growth during cycles of anticancer treatment.

Source: British Journal of Cancer

For more information: www.nature.com/bjc

Related Content

MR-HIFU, ThermoDox, combination therapy, recurrent childhood tumors, Celsion, Children's National Health System, Phase I clinical study
News | Oncology Related Products | December 19, 2016
December 19, 2016 — Children’s National Health System and Celsion Corp.
News | Clinical Decision Support | October 27, 2016
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use
contrast-enhanced ultrasound, CEUS, liver cancer, hepatocellular carcinoma, study, Advances in Contrast Ultrasound conference, ICUS
News | Ultrasound Imaging | September 12, 2016
September 12, 2016 — Tiny microbubbles are being used to more effectively...
cardio-oncology, echo strain assessment, echoinsight, epsilon

Epsilon's EchoInsight software helps analyze cardiac function by evaluating wall motion strain. 

Feature | Cardio-oncology | May 13, 2016 | Dave Fornell
Cardio-oncology is an emerging field that combines the expertise of both cardiology and oncology to assess and treat
Carestream, Clinical Collaboration Platform, Fox Valley Hematology & Oncology
News | Enterprise Imaging | April 20, 2016
Fox Valley Hematology & Oncology (Appleton, Wis.) implemented Carestream’s Vue for Clinical Collaboration Platform...
cancer immunotherapy, development, Axel Hoos, Nature Reviews, imaging
News | Oncology Related Products | March 31, 2016
In a paper published in Nature Reviews last week, Axel Hoos, M.D., Ph.D., laid out the current immunotherapy...
Pyrexar, buy back outside ownership, Person Medical, BSD-2000 Hyperthermia System

BSD-2000 image courtesy of Pyrexar Medical

News | Oncology Related Products | March 15, 2016
Pyrexar announced it has purchased back outside ownership from Person Medical (formerly BSD Medical), concluding a...
BTG, LC Bead LUMI, radiopaque embolic bead, Philips Healthcare, Live Image Guidance, liver cancer
News | Interventional Radiology | February 09, 2016
BTG plc and Royal Philips announced a significant milestone in their collaboration with the treatment of the first...
Overlay Init